شیمی دارویی داروپخش
دشیمی | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Cash Flow
AGM
Interim
2026/05/30 Fiscal Year 2026/03/2012 Month / Audited | 2026/05/19 Fiscal Year 2026/03/2012 Month | ||
|---|---|---|---|
Cash Generated from Operations | 1.782 Trillion | 1.777 Trillion | |
Income Taxes Paid | -403.118 Billion | -403.118 Billion | |
Net Cash Flow from Operating Activities | 1.379 Trillion | 1.374 Trillion | |
Purchases of Property, Plant and Equipment | -100.29 Billion | -94.88 Billion | |
Purchases of Intangible Assets | -45.172 Billion | -45.046 Billion | |
Cash Paid to Acquire Long-Term Investments | -54 Million | -54 Million | |
Dividends Received | 420 Million | - | |
Cash Received from Income on Other Investments | 5.014 Billion | 5.014 Billion | |
Net Cash Flow from Investing Activities | -140.082 Billion | -134.966 Billion | |
Net Cash Flow before Financing Activities | 1.239 Trillion | 1.239 Trillion | |
Cash Received from Borrowings | 3.796 Trillion | 3.796 Trillion | |
Repayments of Borrowings (Principal) | -4.259 Trillion | -4.259 Trillion | |
Interest Paid on Borrowings | -769.594 Billion | -769.595 Billion | |
Dividends Paid | -457.014 Billion | -457.011 Billion | |
Net Cash Flow from Financing Activities | -1.69 Trillion | -1.69 Trillion | |
Net Increase (Decrease) in Cash | -451.849 Billion | -451.849 Billion | |
Cash at Beginning of Period | 756.578 Billion | 756.578 Billion | |
Effect of Exchange Rate Changes | 6.143 Billion | 6.143 Billion | |
Cash at End of Period | 762.721 Billion | 762.721 Billion |